Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Musculoskeletal Disorders Therapeutics market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market is expected to play significant role in the development of demand and improvement due to COVID-19..
Based on the type of product, the global Musculoskeletal Disorders Therapeutics market segmented into
Biologics
Small Molecules
Others
Based on the end-use, the global Musculoskeletal Disorders Therapeutics market classified into
Osteoarthritis
Osteoporosis
Psoriatic Arthritis
Ankylosing Spondylitis
Fibromyalgia
Others
Based on geography, the global Musculoskeletal Disorders Therapeutics market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Pfizer
AbbVie
Johnson & Johnson
Sanofi
Merck
Novartis
Eli Lilly
AstraZeneca
Boehringer Ingelheim
F. Hoffmann-La Roche
Amgen
Takeda Pharmaceutical
Daiichi Sankyo
LG Life Sciences
Astellas
Samsung Bioepis
Zosano Pharma
Taisho Pharmaceutical
3SBio
End of Summary
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL MUSCULOSKELETAL DISORDERS THERAPEUTICS INDUSTRY
2.1 Summary about Musculoskeletal Disorders Therapeutics Industry
2.2 Musculoskeletal Disorders Therapeutics Market Trends
2.2.1 Musculoskeletal Disorders Therapeutics Production & Consumption Trends
2.2.2 Musculoskeletal Disorders Therapeutics Demand Structure Trends
2.3 Musculoskeletal Disorders Therapeutics Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Biologics
4.2.2 Small Molecules
4.2.3 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Osteoarthritis
4.3.2 Osteoporosis
4.3.3 Psoriatic Arthritis
4.3.4 Ankylosing Spondylitis
4.3.5 Fibromyalgia
4.3.6 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Biologics
5.2.2 Small Molecules
5.2.3 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Osteoarthritis
5.3.2 Osteoporosis
5.3.3 Psoriatic Arthritis
5.3.4 Ankylosing Spondylitis
5.3.5 Fibromyalgia
5.3.6 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Biologics
6.2.2 Small Molecules
6.2.3 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Osteoarthritis
6.3.2 Osteoporosis
6.3.3 Psoriatic Arthritis
6.3.4 Ankylosing Spondylitis
6.3.5 Fibromyalgia
6.3.6 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Biologics
7.2.2 Small Molecules
7.2.3 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Osteoarthritis
7.3.2 Osteoporosis
7.3.3 Psoriatic Arthritis
7.3.4 Ankylosing Spondylitis
7.3.5 Fibromyalgia
7.3.6 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Biologics
8.2.2 Small Molecules
8.2.3 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Osteoarthritis
8.3.2 Osteoporosis
8.3.3 Psoriatic Arthritis
8.3.4 Ankylosing Spondylitis
8.3.5 Fibromyalgia
8.3.6 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Biologics
9.2.2 Small Molecules
9.2.3 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Osteoarthritis
9.3.2 Osteoporosis
9.3.3 Psoriatic Arthritis
9.3.4 Ankylosing Spondylitis
9.3.5 Fibromyalgia
9.3.6 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Pfizer
10.1.2 AbbVie
10.1.3 Johnson & Johnson
10.1.4 Sanofi
10.1.5 Merck
10.1.6 Novartis
10.1.7 Eli Lilly
10.1.8 AstraZeneca
10.1.9 Boehringer Ingelheim
10.1.10 F. Hoffmann-La Roche
10.1.11 Amgen
10.1.12 Takeda Pharmaceutical
10.1.13 Daiichi Sankyo
10.1.14 LG Life Sciences
10.1.15 Astellas
10.1.16 Samsung Bioepis
10.1.17 Zosano Pharma
10.1.18 Taisho Pharmaceutical
10.1.19 3SBio
10.2 Musculoskeletal Disorders Therapeutics Sales Date of Major Players (2017-2020e)
10.2.1 Pfizer
10.2.2 AbbVie
10.2.3 Johnson & Johnson
10.2.4 Sanofi
10.2.5 Merck
10.2.6 Novartis
10.2.7 Eli Lilly
10.2.8 AstraZeneca
10.2.9 Boehringer Ingelheim
10.2.10 F. Hoffmann-La Roche
10.2.11 Amgen
10.2.12 Takeda Pharmaceutical
10.2.13 Daiichi Sankyo
10.2.14 LG Life Sciences
10.2.15 Astellas
10.2.16 Samsung Bioepis
10.2.17 Zosano Pharma
10.2.18 Taisho Pharmaceutical
10.2.19 3SBio
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Tables and Figures
List of Table
1.Table Musculoskeletal Disorders Therapeutics Product Type Overview
2.Table Musculoskeletal Disorders Therapeutics Product Type Market Share List
3.Table Musculoskeletal Disorders Therapeutics Product Type of Major Players
4.Table Brief Introduction of Pfizer
5.Table Brief Introduction of AbbVie
6.Table Brief Introduction of Johnson & Johnson
7.Table Brief Introduction of Sanofi
8.Table Brief Introduction of Merck
9.Table Brief Introduction of Novartis
10.Table Brief Introduction of Eli Lilly
11.Table Brief Introduction of AstraZeneca
12.Table Brief Introduction of Boehringer Ingelheim
13.Table Brief Introduction of F. Hoffmann-La Roche
14.Table Brief Introduction of Amgen
15.Table Brief Introduction of Takeda Pharmaceutical
16.Table Brief Introduction of Daiichi Sankyo
17.Table Brief Introduction of LG Life Sciences
18.Table Brief Introduction of Astellas
19.Table Brief Introduction of Samsung Bioepis
20.Table Brief Introduction of Zosano Pharma
21.Table Brief Introduction of Taisho Pharmaceutical
22.Table Brief Introduction of 3SBio
23.Table Products & Services of Pfizer
24.Table Products & Services of AbbVie
25.Table Products & Services of Johnson & Johnson
26.Table Products & Services of Sanofi
27.Table Products & Services of Merck
28.Table Products & Services of Novartis
29.Table Products & Services of Eli Lilly
30.Table Products & Services of AstraZeneca
31.Table Products & Services of Boehringer Ingelheim
32.Table Products & Services of F. Hoffmann-La Roche
33.Table Products & Services of Amgen
34.Table Products & Services of Takeda Pharmaceutical
35.Table Products & Services of Daiichi Sankyo
36.Table Products & Services of LG Life Sciences
37.Table Products & Services of Astellas
38.Table Products & Services of Samsung Bioepis
39.Table Products & Services of Zosano Pharma
40.Table Products & Services of Taisho Pharmaceutical
41.Table Products & Services of 3SBio
42.Table Market Distribution of Major Players
43.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
44.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
45.Table Global Musculoskeletal Disorders Therapeutics Market Forecast (Million USD) by Region 2021f-2026f
46.Table Global Musculoskeletal Disorders Therapeutics Market Forecast (Million USD) Share by Region 2021f-2026f
47.Table Global Musculoskeletal Disorders Therapeutics Market Forecast (Million USD) by Demand 2021f-2026f
48.Table Global Musculoskeletal Disorders Therapeutics Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
1.Figure Global Musculoskeletal Disorders Therapeutics Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Musculoskeletal Disorders Therapeutics Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Musculoskeletal Disorders Therapeutics Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Musculoskeletal Disorders Therapeutics Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Musculoskeletal Disorders Therapeutics Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Musculoskeletal Disorders Therapeutics Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Musculoskeletal Disorders Therapeutics Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Biologics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Small Molecules Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Osteoarthritis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Osteoporosis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Psoriatic Arthritis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Ankylosing Spondylitis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Fibromyalgia Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Biologics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Small Molecules Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Osteoarthritis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Osteoporosis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Psoriatic Arthritis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Ankylosing Spondylitis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Fibromyalgia Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure Biologics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Small Molecules Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Osteoarthritis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Osteoporosis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Psoriatic Arthritis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Ankylosing Spondylitis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Fibromyalgia Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Biologics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Small Molecules Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Osteoarthritis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Osteoporosis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Psoriatic Arthritis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure Ankylosing Spondylitis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Fibromyalgia Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Biologics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Small Molecules Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Osteoarthritis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure Osteoporosis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
72.Figure Psoriatic Arthritis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
73.Figure Ankylosing Spondylitis Segmentation Market Size